Abstract:Highlights • HMGB1/STAT3/p65 axis mediated microglial activation and autophagy in mPFC correlated with MDD were first identified, and HMGB1 was found to be a potential biomarker for MDD. • Increased HMGB1 expression was mainly observed in microglia from the medial prefrontal cortex of MDD model mice. • Specific knockdown of HMGB1 rescues chronic stress-induced depressive-related phenotypes, microglial activation, and autophagy in mice. • The effects induced by chronic stress were mimicked by exogenous administration of recombinant HMGB1 or specific overexpression of HMGB1, while blocked by STAT3 specific inhibitor or p65 knockdown. • Inhibition of HMGB1/STAT3/p65 axis prevented LPS-induced microglial activation and autophagy in vitro , which was reversed by recombinant HMGB1 protein overexpression. • Microglial HMGB1/STAT3/p65 axis within the mPFC is a novel therapeutic target in the treatment of MDD associated with stress. Introduction Neuroinflammation and autophagy are implicated in stress-related major depressive disorder (MDD), but the underlying molecular mechanisms remain largely unknown. Objectives Here, we identified that MDD regulated by HMGB1/STAT3/p65 axis mediated microglial activation and autophagy for the first time. Further investigations were performed to uncover the effects of this axis on MDD in vivo and in vitro . Methods Bioinformatics analyses were used to re-analysis the transcriptome data from the dorsolateral prefrontal cortex (dlPFC) of post-mortem male MDD patients. The expression level of HMGB1 and its correlation with depression symptoms were explored in MDD clinical patients and chronic social defeat stress (CSDS)-induced depression model mice. Specific adeno-associated virus and recombinant (r)HMGB1 injection into the medial PFC (mPFC) of mice, and pharmacological inhibitors with rHMGB1 in two microglial cell lines exposed to lipopolysaccharide were used to analyze the effects of HMGB1/STAT3/p65 axis on MDD. Results The differential expression of genes from MDD patients implicated in microglial activation and autophagy regulated by HMGB1/STAT3/p65 axis. Serum HMGB1 level was elevated in MDD patients and positively correlated with symptom severity. CSDS not only induced depression-like states in mice, but also enhanced microglial reactivity, autophagy as well as activation of the HMGB1/STAT3/p65 axis in mPFC. The expression level of HMGB1 was mainly increased in the microglial cells of CSDS-susceptible mice, which also correlated with depressive-like behaviors. Specific HMGB1 knockdown produced a depression-resilient phenotype and suppressed the associated microglial activation and autophagy effects of CSDS-induced. The effects induced by CSDS were mimicked by exogenous administration of rHMGB1 or specific overexpression of HMGB1, while blocked by STAT3 inhibitor or p65 knockdown. In vitro , inhibition of HMGB1/STAT3/p65 axis prevented lipopolysaccharide-induced microglial activation and autophagy, while rHMGB1 reversed these changes. Conclusion Our study established the role of microglial HMGB1/STAT3/p65 axis in mPFC in mediating microglial activation and autophagy in MDD. Graphical abstract Download : Download high-res image (228KB) Download : Download full-size image

Fr‑HMGB1 and Ds‑hmgb1 Activate the Kynurenine Pathway Via Different Mechanisms in Association with Depressive‑like Behavior

Ds-HMGB1 and Fr-Hmgb Induce Depressive Behavior Through Neuroinflammation in Contrast to Nonoxid-Hmgb1.

HMGB1 Mediates Depressive Behavior Induced by Chronic Stress Through Activating the Kynurenine Pathway.

Upregulation of HDAC9 in Hippocampal Neurons Mediates Depression-Like Behaviours by Inhibiting ANXA2 Degradation

High-mobility Group Box-1 Was Released Actively and Involved in LPS Induced Depressive-Like Behavior.

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression

Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice.

Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress

HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder

Repeated Social Defeat Stress Induces HMGB1 Nuclear Export in Prefrontal Neurons, Leading to Social Avoidance in Mice

Kynurenines Increase MRS Metabolites in Basal Ganglia and Decrease Resting State Connectivity in Frontostriatal Reward Circuitry in Depression

Kynurenines Increase MRS Metabolites in Basal Ganglia and Decrease Resting-State Connectivity in Frontostriatal Reward Circuitry in Depression.

JSH-23 Prevents Depressive-Like Behaviors in Mice Subjected to Chronic Mild Stress: Effects on Inflammation and Antioxidant Defense in the Hippocampus

Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder

Icariin and Icaritin Ameliorated Hippocampus Neuroinflammation Via Mediating HMGB1 Expression in Social Defeat Model in Mice.

The role of HMGB1 in neuroinflammation and tissue repair: A potential therapeutic target for depression?

Inhibition of JNK ameliorates depressive-like behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation

Minocycline Prevents the Depressive-Like Behavior Through Inhibiting the Release of HMGB1 from Microglia and Neurons.

BDNF gene hydroxymethylation in hippocampus related to neuroinflammation-induced depression-like behaviors in mice

Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the "liver-brain" axis